Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Endocrinol Metab Clin North Am. 2011 Sep;40(3):591-614, ix. doi: 10.1016/j.ecl.2011.05.002. Epub 2011 Jul 7.

Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Author information

  • 1Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA. shuk-mei.ho@uc.edu

Abstract

The mainstay targets for hormonal prostate cancer (PCa) therapies are based on negating androgen action. Recent epidemiologic and experimental data have pinpointed the key roles of estrogens in PCa development and progression. Racial and geographic differences, as well as age-associated changes, in estrogen synthesis and metabolism contribute significantly to the etiology. This article summarizes how different estrogens/antiestrogens/estrogen mimics contribute to prostate carcinogenesis, the roles of the different mediators of estrogen in the process, and the potentials of new estrogenic/antiestrogenic compounds for prevention and treatment of PCa.

Copyright © 2011 Elsevier Inc. All rights reserved.

PMID:
21889723
[PubMed - indexed for MEDLINE]
PMCID:
PMC3167093
Free PMC Article

Images from this publication.See all images (1)Free text

Figure. 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk